The global Blood Pressure Monitoring Devices Market size is expected to reach USD 3.24 billion by 2028, according to a new report by Grand View Research. It is expected to expand at a CAGR of 11.2% from 2021 to 2028. The growing geriatric population across the globe is expected to widen the target consumers by triggering incidence rates of hypertension, which is expected to drive the demand for blood pressure monitoring devices. The increasing incidence of hypertension has led to rising demand for cost-effective, rapid, and accurate diagnostic solutions. Blood pressure monitors are one of the vital signs monitors of life. The cost-effective and accurate results offered by these indicators are one of the key factors responsible for market growth.
The ambulatory blood pressure monitors are expected to witness the fastest growth over the forecast period owing to factors such as growing awareness and increasing adoption by clinicians. Automated/digital BP monitors are expected to witness lucrative growth in the coming years owing to advantages associated with these devices, such as ease of use, immediate results, and low cost.
In addition, new product launches, coupled with the rising adoption of technologically advanced products, are fueling the demand for BP monitoring devices. For instance, in April 2016, CareTaker Medical obtained FDA 510(k) clearance for its remote wireless Beat-by-Beat Blood Pressure and Heart Rate Monitor using Finger Cuff technology.
Related Press Release @ Blood Pressure Monitoring Devices Market Report
Blood Pressure Monitoring Devices Market Report Highlights
- Based on product, sphygmomanometer/ aneroid BP monitors dominated the overall market in 2020 in terms of revenue owing to the increasing prevalence of high blood pressure worldwide
- By end use, the home healthcare segment is expected to witness lucrative growth in the forecast period owing to the government initiatives to promote home healthcare
- North America was the leading regional market in terms of revenue in 2020 owing to the presence of advanced healthcare infrastructure and increasing prevalence of lifestyle-associated diseases with a high risk of hypertension
- Asia Pacific is expected to witness rapid growth during the forecast period. This can be attributed to favorable government initiatives, such as the Government of India’s campaign “Make In India”, which is intended to attract FDI and international players to invest in the Indian market